Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOTUM | Q6P988 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | HTR7 | P34969 | 10/20 | 0.48 |
| ▸ | DRD2 | P14416 | 3/20 | 0.46 |
| ▸ | DRD5 | P21918 | 2/20 | 0.46 |
| ▸ | DRD3 | P35462 | 2/20 | 0.46 |
| ▸ | HTR1A | P08908 | 4/20 | 0.46 |
| ▸ | DRD4 | P21917 | 1/20 | 0.44 |
| ▸ | NAMPT | P43490 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6420673 | 0.86 | NOTUM (0.61) | NOTUMMEN1KMT2ANPSR1HTR7 | |
| SCHEMBL2804936 | 0.86 | HTR7 (0.51) | NOTUMHTR7DRD2DRD5DRD3 | |
| SCHEMBL10814252 | 0.80 | AADAT (0.49) | NOTUMMEN1KMT2ANPSR1 | |
| SCHEMBL8240109 | 0.79 | HTR7 (0.57) | NOTUMHTR7DRD2DRD5DRD3 | |
| Bromide SCHEMBL284961 | 0.78 | NAMPT (0.53) | NOTUMMEN1KMT2AHTR7NAMPT | |
| SCHEMBL11980498 | 0.77 | NOTUM (0.64) | NOTUMMEN1KMT2ANPSR1 | |
| SCHEMBL7476444 | 0.76 | DRD2 (0.63) | HTR7DRD2DRD5DRD3HTR1A | |
| SCHEMBL6696116 | 0.76 | HTR7 (0.57) | NOTUMHTR7DRD2DRD5DRD3 | |
| SCHEMBL4815348 | 0.76 | ATAD2 (0.44) | NOTUM | |
| SCHEMBL5113192 | 0.75 | HTR7 (0.53) | NOTUMHTR7DRD2DRD5DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022080473-A1 | NERVE CELL ACTIVATOR | 三沢幸子 | 2022-04-21 | — | — | WO | disclosed |